Generic Avalide is a combination medication used to treat high blood pressure. One component belongs to a class of blood pressure medications that prevents the hormone angiotensin II from constricting the blood vessels, thereby allowing blood to flow more freely and keeping blood pressure down. The other component is a diuretic that increases the output of urine, removing excess fluid from the body and thus lowering blood pressure. More info »
Well, I must apologize - I thought surely you were scamming me. But, all of
a sudden, my mailbox overflows. I received one order on Thursday, 8 June,
and then another on Saturday, 10 June. Almost 1 month from our first
effort, but the postal service must be the culprits. With this double
supply, you are now going to have to send me a couple of women, so the meds
don't go to waste. How can we make this right? What would you like me to
do? Thanks. I hope only good karma comes to you.
- Curt
Loopholes in pharma pricing policy - Hindu Business Line
Hindu Business LineLoopholes in pharma pricing policyHindu Business LineSimilarly in the class of angiotensin II receptor antagonists (also used in high blood pressure), we have losartan potassium in the NLEM 2011 list but not candesartan, irbesartan, telmisartan, valsartan and olmesartan.
Teva Reports First Quarter 2012 Results - MarketWatch (press release)
Proactive Investors USA & CanadaTeva Reports First Quarter 2012 ResultsMarketWatch (press release)Products launched included escitalopram, modafinil, progesterone, irbesartan and irbesartan/HCTZ, quetiapine and olanzapine ODT.
Product launches, Cephalon acquisition drive Teva's Q1 revenues - Drug Store News
Product launches, Cephalon acquisition drive Teva's Q1 revenuesDrug Store News.
Strong Q1 for Sanofi ahead of challenging nine months - PMLiVE
Strong Q1 for Sanofi ahead of challenging nine monthsPMLiVEThe French firm lost exclusivity for high blood pressure treatment Avapro (irbesartan) at the end of March, 2012, with its big-selling blood thinner Plavix (clopidogrel) set to follow in May, resulting in an expected drop in earnings per share for 2012 .
Generic Plavix debuts in US - PMLiVE
Generic Plavix debuts in USPMLiVESanofi and BMS are weathering the impact of two major patent expiries each, with BMS set to lose US patent protection for $1.